☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
satellos
Satellos Reports the First Patient Dosing with SAT-3247 in P-I Trial for Duchenne Muscular Dystrophy
September 19, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.